S. Karlsson et al., PRESYNAPTIC SYMPATHETIC MECHANISM IN THE INSULINOSTATIC EFFECT OF EPINEPHRINE IN MOUSE PANCREATIC-ISLETS, American journal of physiology. Regulatory, integrative and comparative physiology, 41(5), 1997, pp. 1371-1378
The catecholamines inhibit insulin release. It is not established whet
her presynaptic mechanisms contribute to this effect. We therefore exa
mined the relative contribution of presynaptic and postsynaptic mechan
isms to the insulinostatic effects of epinephrine and norepinephrine.
Mice were injected with B-hydroxydopamine (6-OHDA; 0.19 mmol/kg) or it
s vehicle. Islets were isolated after 48 h. Islets from vehicle-inject
ed control animals contained numerous tyrosine hydroxylase (TH)-immuno
reactive nerve terminals (marker for sympathetic nerves). In contrast,
TH-immunoreactive nerves were not detected in islets from 6-OHDA-trea
ted animals, indicating sympathetic denervation. Basal (5.6 mmol/l glu
cose) or glucose-stimulated (16.7 mmol/l) insulin secretion did not di
ffer between incubated islets from vehicle-injected control animals an
d islets from 6-OHDA-treated animals. The insulinostatic effect of epi
nephrine, but not that of norepinephrine, was markedly impaired in isl
ets from 6-OHDA-treated animals: the lowest effective insulinostatic c
oncentration of epinephrine was 0.01 nmol/l in islets from vehicle-inj
ected animals and 1 nmol/l in islets from 6-OHDA-treated animals. We c
onclude that in isolated mouse islets the insulinostatic effect of epi
nephrine, but not that of norepinephrine, partially depends on sympath
etic nerve terminals, suggesting an important role for presynaptic mec
hanisms in epinephrine-induced inhibition of insulin secretion.